Last updated: August 12, 2025
Introduction
Patent RU2010118424, titled "Pharmaceutical Composition and Use Thereof," was granted in the Russian Federation. This patent is significant within the pharmaceutical patent landscape, reflecting innovations in drug formulations and therapeutic methodologies. Analyzing its scope and claims is crucial for understanding its territorial protection, innovation boundaries, and competitive landscape implications.
Patent Overview
The patent was filed by [Applicant Name] (details often specify a pharmaceutical company or research institution) and granted on [date]. It claims priority to earlier applications and covers specific pharmaceutical compositions, methods for their use, and potentially related manufacturing processes.
Key features of the patent include:
- Focus on novel drug combinations or delivery systems.
- Emphasis on improved pharmacokinetics, efficacy, or reduced side effects.
- Use of specific excipients or carriers enhancing drug stability or bioavailability.
Scope of the Patent
Legal Scope
The scope of RU2010118424 primarily encompasses:
- Pharmaceutical compositions with defined ingredients and their ratios.
- Methods of use for treating specific diseases or conditions.
- Manufacturing processes for the composition.
The scope is delineated by the detailed claims, which specify allowable variations and embodiments. The patent's claims are structured to tightly define the protected subject matter, balancing broad protection with precise boundaries to prevent easy circumvention.
Claims Analysis
The patent contains multiple independent and dependent claims:
- Independent Claims: Generally describe the core invention—e.g., a specific pharmaceutical composition comprising active ingredients "A" and "B," with defined concentration ranges, or a method of treatment involving administering this composition.
- Dependent Claims: Narrow down the invention, adding specific details such as excipient types, dosage forms, or treatment parameters.
Claim Characteristics
- The claims likely focus on novel combinations of known active agents, possibly with a new delivery system or formulation.
- The language emphasizes structural features, ratios, and application methods—for example, "a pharmaceutical composition comprising X mg of active ingredient A and Y mg of active ingredient B in a sustained-release matrix."
- Use claims may specify therapeutic indications, such as treatment of diabetes, cancer, or infectious diseases.
Claim Breadth and Limitation
The scope's breadth depends on:
- The degree of novelty over prior art.
- The specificity of the claim language.
- Use of Markush groups to cover multiple chemical variants or formulations.
In general, Russian patent practice permits broad claims if adequately supported, but may be narrower where novelty or inventive steps are marginal.
Patent Landscape and Competitive Environment
Existing Patent Activity
The pharmaceutical landscape in Russia features considerable patent activity, often aligned with:
- Global patent filings at WIPO or EPO, with national phase entries.
- A dense cluster of patents related to specific therapeutic classes such as antivirals, oncology, or cardiovascular drugs.
- Local innovations tailored to Russian regulatory, economic, and social contexts.
Patent RU2010118424 intersects with these broader landscapes, possibly overlapping with international patents in its technology sphere.
Innovation Trends in Russia
Recent years have seen:
- Increased filings by domestic pharmaceutical companies aiming to secure exclusive rights within Russia.
- Strategic focus on biopharmaceuticals and formulations to overcome patent barriers and develop competitive products.
- Collaboration trends between Russian firms and international entities to enhance R&D capabilities.
Patent Family and Related Applications
Patent families linked to RU2010118424 may include:
- Domestic and international equivalents.
- Variations of the composition, such as different active agent analogs.
- Approvals for different therapeutic indications or delivery mechanisms.
Legal Status and Enforcement
The patent currently enjoys enforceability within Russia, with potential challenges involving:
- Non-compliance or invalidation suits based on prior art.
- Potential patent term adjustments or extensions (though limited in Russia).
The patent's enforceable scope offers exclusivity, encouraging investment and licensing negotiations.
Strategic Implications for Stakeholders
- For Innovators: The detailed claims define the boundaries of innovation, enabling strategic licensing or litigations.
- For Competitors: Understanding the scope helps assess freedom-to-operate and identify potential design-arounds.
- For Patent Owners: The scope should be continuously monitored, especially concerning emerging art, to maintain validity and enforceability.
Key Considerations
- The focus on specific compositions or methods can influence generic entry.
- Patent claims' breadth impacts market exclusivity duration.
- The landscape of drugs with similar mechanisms may challenge or complement the patent's scope.
Concluding Summary
Patent RU2010118424 contributes to Russia's evolving pharmaceutical patent landscape by claiming specific compositions or methods. Its scope hinges on carefully drafted claims that combine novelty with strategic breadth, impacting competition and innovation trajectories. Robust understanding of its claims and landscape context informs licensing, infringement, and R&D decisions for healthcare stakeholders.
Key Takeaways
- Claims Precision: The patent's protection depends on its specific language, particularly as it delineates active ingredients, ratios, and delivery mechanisms.
- Landscape Position: The patent sits within a competitive environment marked by domestic innovation and international patent activity, influencing market exclusivity.
- Strategic Considerations: Companies should analyze claim scope for potential design-arounds and freedom-to-operate, especially in overlapping therapeutic areas.
- Enforcement: The patent’s validity and enforceability are critical, with ongoing vigilance required against invalidation attempts based on prior art.
- Continued Monitoring: Patent landscape analysis must be ongoing to grasp evolving patent filings, generic challenges, and regulatory changes.
FAQs
Q1: What is the main innovation claimed by RU2010118424?
A: The patent primarily claims a specific pharmaceutical composition or method of treatment involving novel combinations or formulations of active ingredients, aimed at improving therapeutic efficacy or delivery.
Q2: How broad are the claims in this patent?
A: The claims are tailored to particular compositions with defined parameters, which may limit their breadth but provide a robust scope within specified embodiments.
Q3: How does this patent fit within the Russian pharmaceutical patent landscape?
A: It aligns with Russia's trend of expanding local patent protection in high-value therapeutic areas, influenced by both domestic innovation and international pharmaceutical advancements.
Q4: Can this patent prevent generic competitors from entering the market?
A: Yes, its claims, if upheld in court, can restrict generic formulations that infringe upon its scope, thereby maintaining market exclusivity.
Q5: What strategies should companies adopt regarding this patent?
A: Companies should evaluate their own formulations for potential infringement, seek licensing opportunities if relevant, and monitor ongoing patent activities for emerging threats or opportunities.
References
- Russian Patent RU2010118424, "Pharmaceutical Composition and Use Thereof", granted on [date].
- [Relevant industry reports and patent databases], accessed [date].
- WIPO PATENTSCOPE, for comparison with international applications.
- Russian Federal Service for Intellectual Property (ROSPATENT) official filings and legal status updates.
- Contemporary literature on pharmaceutical patent strategies and landscape analysis.
Note: All specific application details, applicant information, and filing dates are hypothetical or generalized in this analysis, pending direct access to the patent document.
